OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates

OptiNose (OPTN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of$ 0.70. This compares to loss of $1.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 95.71%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.75 per share when it actually produced break-even earnings, delivering a surprise of 100%.Over the last four quarters, the ...